Clinical Trials for iCell Gene Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: iCell Gene Therapeutics

Clinical Trials (5)

NCT06787989
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
PHASE1Recruiting
20 participants
Started: Aug 31, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT06197672
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
PHASE1Recruiting
30 participants
Started: Mar 19, 2024 · Completed: Dec 31, 2042
1 condition2 sponsors3 locations
NCT06071624
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
PHASE1Recruiting
30 participants
Started: Feb 21, 2024 · Completed: Dec 31, 2043
1 condition3 sponsors2 locations
NCT03829540
CD4CAR for CD4+ Leukemia and Lymphoma
PHASE1Recruiting
20 participants
Started: Jul 9, 2020 · Completed: Dec 31, 2040
2 conditions2 sponsors4 locations
NCT04162353
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
PHASE1Recruiting
12 participants
Started: Jul 1, 2019 · Completed: Jul 31, 2026
3 conditions3 sponsors2 locations